Pfizer reports loss as Covid-19 revenues shrink
Pfizer said it is midway through a "cost realignment" program that will yield $3.5 billion in annual savings through 2024.
PREMIUM World
Pfizer said it is midway through a "cost realignment" program that will yield $3.5 billion in annual savings through 2024.
